MiNK Therapeutics, Inc.(INKT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INKT MiNK Therapeutics, Inc.

盘后交易 11-22 19:35:32 EST

0.6800

-0.0100

-1.46%

盘后0.6911

+0.0111+1.63%

19:17 EST

最高0.7100	最低0.6707	成交量3.57万
今开0.6900	昨收0.6901	日振幅5.70%
总市值2,689万	流通市值686.04万	总股本3,954万
成交额2.45万	换手率0.35%	流通股本1,009万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"INKT","market":"US","secType":"STK","nameCN":"MiNK Therapeutics, Inc.","latestPrice":0.68,"timestamp":1732309200000,"preClose":0.69005,"halted":0,"volume":35692,"hourTrading":{"tag":"盘后","latestPrice":0.6911,"preClose":0.68,"latestTime":"19:17 EST","volume":175,"amount":121.705493,"timestamp":1732321078586},"delay":0,"floatShares":10088808,"shares":39539689,"eps":-0.48535,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.01005,"latestTime":"11-22 19:35:32 EST","open":0.69,"high":0.71,"low":0.6707,"amount":24486.07757592,"amplitude":0.056952,"askPrice":0.73,"askSize":121,"bidPrice":0.65,"bidSize":144,"shortable":3,"etf":0,"ttmEps":-0.48535,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732323600000},"adr":0,"listingDate":1634270400000,"adjPreClose":0.69005,"preHourTrading":{"tag":"盘前","latestPrice":0.6999,"preClose":0.6801,"latestTime":"09:18 EST","volume":832,"amount":589.0332864,"timestamp":1732285117326},"postHourTrading":{"tag":"盘后","latestPrice":0.6911,"preClose":0.68,"latestTime":"19:17 EST","volume":175,"amount":121.705493,"timestamp":1732321078586},"volumeRatio":1.103621},"requestUrl":"/m/hq/s/INKT/wiki","defaultTab":"wiki","newsList":[{"id":"2485298786","title":"Mink Therapeutics, Inc.2024财年第三财季实现净利润-1.81百万美元，同比增加64.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298786?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:02","pubTimestamp":1732291336,"startTime":"0","endTime":"0","summary":"11月23日，Mink Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-1.81百万美元，同比增加64.65%；其中营业收入为0.00美元，每股基本收益为-0.05美元。从资产负债表来看，Mink Therapeutics, Inc.总负债24.93百万美元，其中短期债务0.00美元，资产负债比为0.30，流动比率为0.89。机构评级：截至2024年11月23日，当前有2家机构对Mink Therapeutics, Inc.目标价做出预测，其中目标均价为6.50美元，其中最低目标价为4.00美元，最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000240a24e495e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000240a24e495e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INKT"],"gpt_icon":0},{"id":"2484674990","title":"Mink Therapeutics, Inc.盘中异动 早盘急速下挫5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484674990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484674990?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:23","pubTimestamp":1731943415,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时23分，Mink Therapeutics, Inc.股票出现波动，股价急速下挫5.82%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118232336a243432b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118232336a243432b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2482088891","title":"Mink Therapeutics Inc    预计每股亏损 8 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482088891","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482088891?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:13","pubTimestamp":1731420790,"startTime":"0","endTime":"0","summary":"   * Mink Therapeutics Inc     预计将于11月14日公布截至2024年9月30日的业绩报告。*    * LSEG分析师对Mink Therapeutics Inc的平均预期是每股亏损8美分。* 华尔街对 Mink Therapeutics Inc 的 12 个月目标价中位数为 8.00 美元，高于其最新收盘价 0.75 美元。11月12日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","LENZ"],"gpt_icon":0},{"id":"2481530218","title":"Mink Therapeutics, Inc.盘中异动 下午盘快速上涨5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481530218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481530218?lang=zh_cn&edition=full","pubTime":"2024-11-05 02:31","pubTimestamp":1730745100,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日02时31分，Mink Therapeutics, Inc.股票出现波动，股价快速拉升5.75%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105023141971a43b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105023141971a43b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2480889595","title":"Mink Therapeutics, Inc.盘中异动 早盘股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480889595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480889595?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:32","pubTimestamp":1730467976,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时32分，Mink Therapeutics, Inc.股票出现波动，股价大幅下挫5.18%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121325695bdab2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121325695bdab2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","INKT"],"gpt_icon":0},{"id":"2479844030","title":"Mink Therapeutics, Inc.盘中异动 临近午盘急速下跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479844030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479844030?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:45","pubTimestamp":1730389533,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时45分，Mink Therapeutics, Inc.股票出现波动，股价快速下挫5.69%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.47%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031234533a202bd82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031234533a202bd82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","INKT"],"gpt_icon":0},{"id":"2477353324","title":"Mink Therapeutics, Inc.盘中异动 快速拉升5.51%报0.729美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477353324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477353324?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:07","pubTimestamp":1729606062,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时07分，Mink Therapeutics, Inc.股票出现异动，股价急速上涨5.51%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102222074298e3dc8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102222074298e3dc8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2477000863","title":"Mink Therapeutics, Inc.盘中异动 早盘快速上涨6.00%报0.724美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477000863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477000863?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:30","pubTimestamp":1729517439,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时30分，Mink Therapeutics, Inc.股票出现波动，股价大幅上涨6.00%。截至发稿，该股报0.724美元/股，成交量1059股，换手率0.00%，振幅0.00%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213039971a15ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213039971a15ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INKT","LENZ"],"gpt_icon":0},{"id":"2460291717","title":"Mink Therapeutics, Inc.2024财年第二财季实现净利润-2.70百万美元，同比增加56.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460291717","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460291717?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:04","pubTimestamp":1723997065,"startTime":"0","endTime":"0","summary":"8月19日，Mink Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-2.70百万美元，同比增加56.45%；其中营业收入为0.00美元，每股基本收益为-0.07美元。从资产负债表来看，Mink Therapeutics, Inc.总负债26.90百万美元，其中短期债务0.00美元，资产负债比为0.39，流动比率为0.94。机构评级：截至2024年8月19日，当前有2家机构对Mink Therapeutics, Inc.目标价做出预测，其中目标均价为8.50美元，其中最低目标价为8.00美元，最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190004439f363dd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190004439f363dd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","LENZ"],"gpt_icon":0},{"id":"2458451002","title":"Mink Therapeutics Inc    预计每股亏损 10 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458451002","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458451002?lang=zh_cn&edition=full","pubTime":"2024-08-10 02:53","pubTimestamp":1723229589,"startTime":"0","endTime":"0","summary":"   * Mink Therapeutics Inc     将于8月13日公布截至2024年6月30日的财报，预计季度收入将保持不变。*    * LSEG 的分析师平均预计 Mink Therapeutics Inc 每股亏损 10 美分。* 华尔街对 Mink Therapeutics Inc 的 12 个月目标价中位数为 8.00 美元，高于上一交易日 0.81 美元的收盘价。8月9日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","INKT"],"gpt_icon":0},{"id":"2457770394","title":"Mink Therapeutics, Inc.盘中异动 临近午盘股价大跌5.68%报0.823美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457770394","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457770394?lang=zh_cn&edition=full","pubTime":"2024-08-05 23:54","pubTimestamp":1722873257,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日23时54分，Mink Therapeutics, Inc.股票出现波动，股价大幅下挫5.68%。截至发稿，该股报0.823美元/股，成交量6.3445万股，换手率0.16%，振幅3.72%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.05%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805235417aefd4ffa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805235417aefd4ffa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2456143926","title":"Mink Therapeutics, Inc.盘中异动 股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456143926","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456143926?lang=zh_cn&edition=full","pubTime":"2024-08-01 22:30","pubTimestamp":1722522638,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日22时30分，Mink Therapeutics, Inc.股票出现波动，股价急速跳水5.32%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801223039aefcb7bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801223039aefcb7bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INKT"],"gpt_icon":0},{"id":"2452275474","title":"Mink Therapeutics, Inc.股价飙升15.63% 市值涨19.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452275474","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452275474?lang=zh_cn&edition=full","pubTime":"2024-07-19 22:19","pubTimestamp":1721398783,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日22时19分，Mink Therapeutics, Inc.股票出现异动，股价大幅上涨15.63%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719221944af9331b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719221944af9331b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2451918798","title":"Mink Therapeutics, Inc.盘中异动 早盘急速下挫6.14%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451918798","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451918798?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:56","pubTimestamp":1721138178,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时56分，Mink Therapeutics, Inc.股票出现异动，股价大幅跳水6.14%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215618941f7728&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716215618941f7728&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INKT"],"gpt_icon":0},{"id":"2451238316","title":"Mink Therapeutics, Inc.盘中异动 早盘股价大涨6.60%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451238316","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451238316?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:38","pubTimestamp":1721050686,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时38分，Mink Therapeutics, Inc.股票出现异动，股价急速上涨6.60%。截至发稿，该股报1.19美元/股，成交量2.248万股，换手率0.06%，振幅2.68%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213806af92650b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213806af92650b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2450245533","title":"Mink Therapeutics, Inc.盘中异动 股价大涨6.32%报1.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450245533","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450245533?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:33","pubTimestamp":1720791189,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时33分，Mink Therapeutics, Inc.股票出现异动，股价快速上涨6.32%。截至发稿，该股报1.030美元/股，成交量2.8128万股，换手率0.07%，振幅4.66%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213309af921cab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213309af921cab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INKT"],"gpt_icon":0},{"id":"2450350006","title":"Mink Therapeutics, Inc.盘中异动 急速拉升5.74%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450350006","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450350006?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:30","pubTimestamp":1720704633,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时30分，Mink Therapeutics, Inc.股票出现波动，股价大幅上涨5.74%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.43%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213033af91dd0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213033af91dd0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INKT","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.minktherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0799},{"period":"1month","weight":-0.0416},{"period":"3month","weight":-0.1585},{"period":"6month","weight":-0.2812},{"period":"1year","weight":-0.3428},{"period":"ytd","weight":-0.3551}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MiNK Therapeutics, Inc.于2017年7月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，率先发现、开发和商业化同种异体、现成的iNKT细胞疗法，以治疗癌症和其他免疫介导的疾病。该公司正在利用其平台和制造能力开发一条全资或独家许可的天然和工程iNKT细胞管道，并预计在2021年和2022年进行多项临床和临床前读数。公司的战略是推进可访问、可扩展且有效的细胞治疗平台，利用iNKT细胞的先天和持久的生物学优势，优化可扩展性和快速临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.192622},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.048119},{"month":3,"riseRate":0,"avgChangeRate":-0.107679},{"month":4,"riseRate":0.333333,"avgChangeRate":0.010032},{"month":5,"riseRate":0,"avgChangeRate":-0.114999},{"month":6,"riseRate":0.333333,"avgChangeRate":0.027139},{"month":7,"riseRate":0,"avgChangeRate":-0.063379},{"month":8,"riseRate":0.333333,"avgChangeRate":0.214912},{"month":9,"riseRate":0,"avgChangeRate":-0.171057},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.029184},{"month":11,"riseRate":0.5,"avgChangeRate":-0.035032},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.203854}],"exchange":"NASDAQ","name":"MiNK Therapeutics, Inc.","nameEN":"MiNK Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MiNK Therapeutics, Inc.(INKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MiNK Therapeutics, Inc.(INKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MiNK Therapeutics, Inc.,INKT,MiNK Therapeutics, Inc.股票,MiNK Therapeutics, Inc.股票老虎,MiNK Therapeutics, Inc.股票老虎国际,MiNK Therapeutics, Inc.行情,MiNK Therapeutics, Inc.股票行情,MiNK Therapeutics, Inc.股价,MiNK Therapeutics, Inc.股市,MiNK Therapeutics, Inc.股票价格,MiNK Therapeutics, Inc.股票交易,MiNK Therapeutics, Inc.股票购买,MiNK Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MiNK Therapeutics, Inc.(INKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MiNK Therapeutics, Inc.(INKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}